Parkman Healthcare Partners’s Apollo Endosurgery, Inc. APEN Stock Holding History

Parkman Healthcare Partners’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-657,690	Closed	-$3.62M	–	100
2022 Q3	$3.62M	Buy	657,690 +7,690	+1%	+$42.6K	1.03%	35
2022 Q2	$2.37M	Sell	650,000 -160,411	-20%	-$758K	0.87%	40
2022 Q1	$4.9M	Sell	810,411 -108,074	-12%	-$659K	1.43%	27
2021 Q4	$7.74M	Buy	918,485 +87,271	+10%	+$762K	1.71%	22
2021 Q3	$7.53M	Buy	831,214 +140,000	+20%	+$1.2M	1.91%	20
2021 Q2	$5.6M	Buy	691,214 +616,214	+822%	+$4.23M	1.22%	30
2021 Q1	$413K	Buy	+75,000	New	+$371K	0.1%	82

Other funds holding APEN

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Parkman Healthcare Partners's APEN Position: Q4 2022 in Review

Parkman Healthcare Partners sold out of Apollo Endosurgery, Inc. (APEN) in Q4 2022, closing a stake of 657,690 shares — an estimated $3.62M sold.

Parkman Healthcare Partners first reported a position in APEN in Q1 2021 and held it in 7 quarters. The position peaked at $7.74M in Q4 2021. 81 funds tracked by Wall St. Rank hold APEN as of Q4 2022.

Parkman Healthcare Partners reported no remaining Apollo Endosurgery, Inc. position as of Q4 2022 after selling out during the quarter.
Parkman Healthcare Partners sold 657,690 Apollo Endosurgery, Inc. shares in Q4 2022, an estimated $3.62M.
Parkman Healthcare Partners first reported a position in Apollo Endosurgery, Inc. in Q1 2021 and held it in 7 quarters.
Parkman Healthcare Partners's Apollo Endosurgery, Inc. position peaked at $7.74M in Q4 2021.
81 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q4 2022.

Based on Parkman Healthcare Partners's 13F filing for Q4 2022, filed 13 Feb 2023.